Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Priya Nigam

Why This Analyst Believes Ameresco Is Oversold

While Ameresco Inc.’s (NYSE:AMRC) shares are down due to the disappointing BBB legislative and rates, as well as leverage factors and concerns around its delayed Analyst Day, according to BofA Securities the company offers “superior EBITDA growth (high-teens)” and the potential of a positive reset of long-term estimates.

The Ameresco Analyst: Julien Dumoulin-Smith upgraded the rating for Ameresco from Neutral to Buy, while reducing the price target from $88 to $61.

The Ameresco Thesis: The company’s core RNG-led growth strategy remains on track, with a slight improvement in D3 pricing, Dumoulin-Smith said in the upgrade note.

There should be “further angles for growth announced at the Analyst day, emphasizing recent wins in storage in ’22,” the analyst said. “SCE could see further expansion in ’23,” he added.

“The latest market volatility leads us to take a more conservative valuation approach, particularly with recent renewable declines. We not only reduce our baseline multiples across peers, we also substantively haircut the relative discounts ascribed to AMRC segments too vs these peers,” Dumoulin-Smith wrote to explain the price target reduction.

AMRC Price Action: Shares of Ameresco are down 0.54% to $49.73 at the time of publication Wednesday.

Photo by Zbynek Burival on Unsplash

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.